A Multicenter Randomized Controlled Trial of High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Stem Cell Transplant versus Best Available Approved Therapy for Treatment-Resistant Relapsing Multiple Sclerosis - Fixed Rate

Project: Research project

Project Details

StatusActive
Effective start/end date2/1/241/31/28

Funding

  • Benaroya Research Institute at Virginia Mason (FY24ITN639 // 5UM1AI109565-11)
  • National Institute of Allergy and Infectious Diseases (FY24ITN639 // 5UM1AI109565-11)